ArticleClinical case reports2025
Atypical Presentation of Anti-NMDAR Encephalitis in an Elderly Male With Dominated Memory Impairment From Damascus Hospital.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a rare but serious autoimmune disorder that is typically characterized by a broad spectrum of psychiatric and neurological symptoms. In the academic literature, memory deficits often occur alongside psychiatric symptoms, seizures, motor dysfunctions, and other cognitive issues; it is rare to find it dominated by memory impairment with only one previous seizure. We present a unique presentation of anti-NMDAR encephalitis in a 70-year-old Middle Eastern male patient who primarily exhibited memory impairment along with one unrepeated recent seizure. The patient's initial clinical picture did not align with the classic presentation of anti-NMDAR encephalitis, which often includes prominent psychiatric symptoms and neurological features of motor dysfunction. However, brain magnetic resonance imaging (MRI), electroencephalography (EEG), and the presence of anti-NMDAR antibodies in the cerebrospinal fluid support the diagnosis. Physicians should be aware to consider anti-NMDAR encephalitis in patients with memory impairment and a single previous seizure, even in the absence of typical psychiatric or neurological features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.